Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis

被引：0
作者：
Anil Pooran
Helen Booth
Robert F Miller
Geoff Scott
Motasim Badri
Jim F Huggett
Graham Rook
Alimuddin Zumla
Keertan Dheda
机构：
[1] University College London Medical School,Centre for Infectious Diseases and International Health, Division of Infection and Immunity
[2] University College London,Department of Population Sciences and Primary Care
[3] TB Clinic,Division of Pulmonology and UCT Lung Institute, Department of Medicine
[4] University College London Hospitals NHS Trust,Institute of Infectious Diseases and Molecular Medicine
[5] University College London Medical School,undefined
[6] University College London,undefined
[7] University of Cape Town & Groote Schuur Hospital,undefined
[8] University of Cape Town,undefined
来源：
BMC Pulmonary Medicine | / 10卷
关键词：
Incremental Cost; Tuberculin Skin Test; Cost Effective Strategy; Single Strategy; Dual Strategy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 242 条
  • [1] Dheda K(2005)Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis Curr Opin Pulm Med 11 195-202
  • [2] Udwadia ZF(2007)Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research Annals of internal medicine 146 340-354
  • [3] Huggett JF(2004)Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review Lancet Infect Dis 4 761-776
  • [4] Johnson MA(2008)Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update Annals of internal medicine 149 177-184
  • [5] Rook GA(2006)False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 10 1192-1204
  • [6] Menzies D(2007)Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy Chest 131 1898-1906
  • [7] Pai M(2005)Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States MMWR Recomm Rep 54 49-55
  • [8] Comstock G(2007)Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany Chest 131 1424-1434
  • [9] Pai M(2007)Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis Eur Respir J 30 321-332
  • [10] Riley LW(2009)Enhanced cost-benefit analysis of strategies for LTBI screening and INH chemoprevention in Germany Respiratory medicine 103 1838-1853
12345678910